Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00984243 · ClinicalTrials.gov registry record · NA

Photodynamic Therapy (PDT) in Lung Cancer

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
35
Enrollment target

NCT00984243: Completed NA study, sponsored by Mayo Clinic.

NCT00984243 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00984243, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

This study is being done to determine whether a substance called hematoporphyrin can be used to treat tumors in various locations in the body when used in association with a laser. Hematoporphyrin is a substance that is taken up by cancerous cells. When these cells are exposed to the energy emitted by a laser source, chemical reactions occur in the cell and cause the cells to die. It is hoped that this treatment method may be able to selectively destroy malignant cells without damaging surrounding healthy tissue.

Interventions

  • PROCEDURE PHOTODYNAMIC THERAPY (PDT)

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 1994-02
Est. Completion 2006-10
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT00984243

The ClinicalTrials.gov registry entry for NCT00984243 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which PHOTODYNAMIC THERAPY (PDT) is the first listed.

NCT00984243 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00984243 about?

NCT00984243 is a clinical study titled "Photodynamic Therapy (PDT) in Lung Cancer". This study is being done to determine whether a substance called hematoporphyrin can be used to treat tumors in various locations in the body when used in association with a laser. Hematoporphyrin is a substance that is taken up by cancerous cells. When these cells are exposed to the energy emitted ...

What is the current status of trial NCT00984243?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 1994-02. Estimated completion is 2006-10.

What interventions are being tested in trial NCT00984243?

The interventions under investigation include: PHOTODYNAMIC THERAPY (PDT) (PROCEDURE).

Who is sponsoring clinical trial NCT00984243?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.